What is Edge Biomedical?
Edge Biomedical, also known as EMSAR, operates as a prominent nationwide provider of medical device services. The company specializes in comprehensive asset management, preventative maintenance, corrective action, installation, and depot biomedical services. Its diverse clientele spans emergency medical services, animal health, hospitals, and broader healthcare & life sciences sectors. EMSAR's core mission is to optimize the performance of medical devices, thereby enhancing patient outcomes. With an extensive operational footprint across the U.S. and Canada, EMSAR is dedicated to delivering consistent and innovative service solutions.
How much funding has Edge Biomedical raised?
Edge Biomedical has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Edge Biomedical
PPP
Public-Private Partnership
What's next for Edge Biomedical?
The substantial capital infusion, particularly the recent strategic investment, positions Edge Biomedical for accelerated growth and enhanced service delivery capabilities. This funding is likely to support the expansion of its nationwide operations, further development of its service offerings, and potentially strategic acquisitions. As a company focused on critical infrastructure for healthcare providers, Edge Biomedical's continued investment in its services indicates a strong outlook for maintaining and growing its market share in the competitive medical device services industry.
See full Edge Biomedical company page
